Analysts Set Versigent (NYSE:VGNT) PT at $49.67

Versigent (NYSE:VGNT) has earned a consensus rating of “Buy” from the thirteen research firms that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold rating, nine have given a buy rating and three have given a strong buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $49.6667.

A number of research firms have weighed in on VGNT. UBS Group decreased their target price on shares of Versigent from $58.00 to $55.00 and set a “buy” rating on the stock in a research note on Thursday, July 9th. Oppenheimer set a $50.00 price target on Versigent in a research note on Tuesday, July 21st. Argus set a $50.00 price objective on Versigent in a report on Tuesday, July 21st. Morgan Stanley initiated coverage on Versigent in a research report on Friday, May 8th. They set an “overweight” rating and a $51.00 price objective on the stock. Finally, The Goldman Sachs Group started coverage on Versigent in a report on Monday, July 20th. They issued a “buy” rating and a $48.00 target price for the company.

Versigent Stock Down 2.9%

VGNT stock opened at $42.88 on Monday. The stock’s 50 day moving average is $43.25. Versigent has a 1 year low of $26.34 and a 1 year high of $50.88.